TMDX TransMedics Group, Inc.
Platform & Compounding FCF
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 25%
D- 30
  • 5yr Avg ROIC -6.3%
  • Operating Margin Trend +33.86 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -9.4%
  • 5yr Share-Count CAGR 10.4%

Growth Quality

Weight: 25%
A+ 100
  • 5yr Revenue CAGR 88.2%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
F 0
  • 5yr FCF Margin -48.9%
  • 5yr FCF/NI Conversion -0.79x

Balance Sheet

Weight: 10%
A 90
  • Net Debt / EBITDA -0.13x
  • Interest Coverage (EBIT/Int) 8.80x
  • Altman Z-Score 3.91

Stability

Weight: 5%
A 88
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 7

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

2 of 3 gurus held; 1 added; 3 full exits.

Holders
2 -1
Avg Δ position
+22.8%
New buys
0
Full exits
3
As of Q2 2026